eating concept I teach inside The Holy Weigh
Resmetirom, the first and only FDA-approved agent against MASH, is an orally active, liver-selective agonist of the thyroid hormone receptor [62]
That can happen when dose and timing are off, or when the body clock is already fine
Our study builds upon this by demonstrating that the magnitude of CV death reduction with semaglutide is comparable between T2D patients and overweight or obese patients without T2D, extending to MACE, expanded MACE, and nonfatal stroke
Demonstrating that a purified protein stimulates GLP-1 release in isolated L cells is not the same as demonstrating that an oral probiotic capsule, after surviving stomach acid and reaching the colon, will colonize effectively and produce enough P9 to meaningfully increase systemic GLP-1 levels in a human being